Figure 1

Figure 2

   

 

GROUP-1

NSTEMI

n(%)

GROUP-2

STEMI

n(%)

p-VALUE

AGE

>50

15 (25 )

24(40)   

0.07

<50

45(75)  

36(60)  

 

SEX

MALE

49(64.83)  

44(73.33)  

0.172

FEMALE

11(35.17)  

16(26.67)  

SMOKING

NON SMOKER

22(36.66)  

28(46.66)

0.465

SMOKER

28(63.34)  

32(53.34)

ALCOHOL

NON -ALCOHOL

48(80)  

38(73.65)

0.043

ALCOHOL

12(20)  

22(26.35)

PHYSICAL ACTIVITY

REGULAR

15(25)  

11(18.33)

0.375

INTERMITTENT

45(75)  

49(81.66)

WEIGHT (kgs)

<50

13(21.66)  

11(18.33)

 

>50

47(78.33)  

49(51.04)

DM

NO

45(75.00)

45(75.00)

1.000

YES

15(25.0)

15(25.0)

BP

90- 130

30(50.0)  

36(60.0)

0.197

>130

30(50.0)  

22(36.6)

<90

0(0.00)   

1(1.66)

KILLIP

HEMODYNAMI

NO CLASS

1(1.66)  

2(3.33)

0.275

CLASS 1

28(46.6)  

39(65.0)

CLASS 2

14(23.3)  

8(13.33)

CLASS 3

8(13.33)  

5(8.33)

CLASS 4

9(15.0 )

6(1.0)

CHF

NO

41(68.33)  

43(71.66)

0.690

YES

19(31.66)  

17(28.33)

Hemoglobin

>9

57(95.0)  

60(100.0)

0.122

<9

3(5.00)

0(0.00)

Hematocrit

41-53

18(30.0)  

22(36.66)

0.439

1>53

42(70.0)  

38(63.33)

Platelet count

<1.5

48(80.00)  

52(86.66)

0.327

>4.5

12(20.00)  

8(13.33)

Total leucocyte count

10000

48(80.0)  

42(70)

0.386

>10000

10(16.66)   

17(28.33)

<4000

2(3.33)  

1(1.66)

ESR

MALE<17, FEMALE<25

16(26.66)  

35(58.33)

0.000

MALE>17,

FEMALE>25

44(73.33)  

25(41.66)

GLUCOSE

UPTO 140

51(85.0)  

50(83.33)

0.636

>140

9(15)  

10(16.66)

Dyslipidemia

 

NO

36(60)  

35(58.33)

0.853

YES

24(40)  

25(41.66)

CRP

 

UPTO 3

28(46.66)  

31(51.66)

0.584

>3

32(53.33)  

29(48.33)

TR0P0NIN-I

NEGATIVE

39(65.0)  

34(56.66)

0.453

POSITIVE

21(35.0)  

25(43.33)

CK

 

 

43(71.66)  

26(43.33)

0.002

 

17(28.33)  

34(56.66)

CK-MB

8.5(0.1-267)

8(0.8-414)

0.637

Coagulopathy

NO

58(96.66)  

52(86.66)

0.047

YES

2(3.33)  

8(13.33)

Site of infraction

 

ANTERIOR

33(55.0)  

33(55.00)

1.000

INFERIOR

26(43.33)  

25(41.66)

POSTERIOR

1(1.66)  

2(3.33)

 

Table: 1. Baseline characteristics of Study participants

CYTOKINE

GROUP 1`

STEMI

Median

(Min-Max)

GROUP 2

NSTEMI

Median

(Min-Max)

GROUP 3

CONTROLS

Median

(Min-Max)

P –VALUE OVERALL

 1 VS 2

  1 VS 3

2VS3

IL 6 -day 0

5.16

(0- 304.48)

1.07

(0 - 261.87 )

0.30

(0 -10.83)    

0.0001

0.0026

0.0000

0.0145

IL 6- day 3

8.26

(0-324.05)

1.14

(0 -412.46)

0.30

(0 -10.83)

0.0001

0.0005

0.0000

0.0152

P VALUE

0.123

0.513

---

---

---

---

---

IL 10 -day 0

1.87

(0- 143.05)

1.84

(0 -243.80)  

1.42

(0 -189.16)      

0.8157

----

---

---

IL10 –day 3

2.96

(0 -143.57)

2.18

(0 -64.70)  

1.42

(0 -189.16)      

0.1032

---

---

---

P VALUE

0.000

0.485

---

---

---

---

---

IL 18 –day 0

434.95

(23.93 -4805.13)

263.08

(0 - 4872.10)

46.51

( 0 - 495.81)

0.0001

0.8604

0.0000

0.0000

IL 18- day 3

123.73

(0-1935.11)

108.40

(0-3763.62)

46.51

( 0 - 495.81)

0.0005

0.1538

0.0025

0.0005

P VALUE

0.000

0.002

---

----

----

----

----

TNF alpha -day 0

33.48

( 0 - 98.89 )

60.68

(0 - 634.43)

6.37

( 0 -866.86)     

 0.0001

0.0000

0.0000

0.0000

TNF alpha-day 3

33.48

(9.41 - 216.43 )

43.53 (6.61 - 412.46)

6.37

(0 -866.86)     

0.0001

0.0212

0.0000

0.0000

P VALUE

0.6540

0.0088

-----

----

-----

----

----

Table.2. Correlation of different cytokines